ICU Medical Projects Strong 2026 Guidance Amid Logistics Normalization
ICU Medical (ICUI) reported third-quarter revenue of $556 million, representing a 5% organic growth rate and a 4% reported increase. CEO Vivek Jain highlighted strong financial performance, noting that adjusted gross margins reached just over 42% during the period. Looking ahead to fiscal year 2026, the company provided optimistic guidance, signaling that results are trending toward the high end of its projected EBITDA range of $415 million to $435 million. Additionally, earnings per share (EPS) are expected to fall within the $8.60 to $9.00 range as logistics consolidation processes normalize.
Tickers: $ICUI
Topics: earnings call gross margins revenue growth
Read the full article at Seeking Alpha
Part of the story Kelly Services Projects Q4 Adjusted EBITDA Margin Between 3.8% and 4% (21 articles)